TVGN Stock Summary and Trading Ideas (Tevogen | NASDAQ:TVGN)

Tevogen Inc is a healthcare enterprise engaged in biotechnology, artificial intelligence and technology, and healthcare services. Its operations focus on the development of biotechnology products, AI- and technology-based healthcare solutions, and healthcare service initiatives.

Tevogen trades on the NASDAQ stock market under the symbol TVGN.

As of September 4, 2026, TVGN stock price climbed to $7.34 with 1,938 million shares trading.

TVGN has a beta of 2.92, meaning it tends to be more sensitive to market movements. TVGN has a correlation of 0.09 to the broad based SPY ETF.

TVGN has a market cap of $47.79 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that TVGN belongs to (by Net Assets): VTI, VXF.

TVGN has underperformed the market in the last year with a return of -83.3%, while the SPY ETF gained +19.8%. In the last 3 month period, TVGN fell short of the market, returning -25.6%, while SPY returned +2.0%. However, in the most recent 2 weeks TVGN has outperformed the stock market by returning +8.7%, while SPY returned +0.6%.

TVGN support price is $6.56 and resistance is $7.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TVGN shares will trade within this expected range on the day.